Our analysis strongly support the positive involvement of ACE2 in pro- and anti-tumor cytokines (Fig. 3) and modulation of immune cells (Fig. 4) in the case of luminal A subtype predicting a strong rationale for the consequence of ACEIs in promoting breast cancer progression (Fig. 5). This evidence concerns the gene ACE2 and breast carcinoma.